Platelet-rich plasma treats lateral epicondylar tendinopathy in study

07/11/2013 | Healio

Researchers from Stanford University Medical Center found that leukocyte-enriched platelet-rich plasma safely eased pain and treated chronic lateral epicondylar tendinopathy, or tennis elbow. The trial involved 230 patients. Researchers reported an 83.9% treatment success rate in the PRP therapy group, compared with 68.3% in the control group.

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD